Search

everythinglearnresearchcommunity

for

Search:↓

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.

Folliculitis Decalvans and Frontal Fibrosing Alopecia can coexist in people with darker skin, showing features of both conditions.

People with Alopecia Areata often have thyroid problems like Hashimoto thyroiditis and hypothyroidism.

Some factors like thyroid disease, diabetes treatment, hair dryers, natural hairstyles, and scalp conditions can affect the treatment results for a hair loss condition called CCCA.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

People with alopecia have a higher risk of thyroid cancer.

The research found that certain characteristics like age, sex, race, marital status, and education level can influence whether alopecia patients stick to their hair loss treatment with topical minoxidil.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

Men with genetic hair loss are more likely to have abnormal blood lipid levels, especially if the hair loss is severe.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Trichoscopy is a useful, non-invasive way to diagnose different types of hair loss.

"Christmas tree" pattern helps diagnose female hair loss.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Some breast cancer chemotherapy can cause permanent hair loss.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

Sunlight worsens hair loss; protect scalp.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.

Androgens may block hair growth signals, targeting this could treat hair loss.

The pseudo 'fringe sign' can also appear in frontal fibrosing alopecia, not just in traction alopecia, showing that this condition may be more common than thought.

Hair loss affects quality of life, self-esteem, and confidence, but younger patients cope better.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Hair loss in male pattern baldness involves muscle degeneration and increased scalp fat.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Increasing ABC transporters in hair follicles may prevent chemotherapy-induced hair loss.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.